Institute of Medical Sciences, Tzu-Chi University, Hualien, Taiwan.
Department of Otolaryngology, Tzu-Chi University, Hualien, Taiwan.
Am J Pathol. 2014 Feb;184(2):418-30. doi: 10.1016/j.ajpath.2013.10.012.
The tumor-suppressive activity of prostate apoptosis response-4 (Par-4) has been demonstrated in a variety of human cancers. In this study, for the first time to our knowledge, we demonstrated that a higher intensity of Par-4 was significantly correlated with a better response in patients with hypopharyngeal carcinoma undergoing radiotherapy alone or concurrent chemoradiotherapy. Mechanistically, an elevated expression of Par-4 induced apoptosis of hypopharyngeal carcinoma cells and sensitized cells toward chemotherapeutic agents or X-ray irradiation. Along with apoptotic incitation, intriguingly, autophagic flux also increased on Par-4 stimulation and contributed to cell death. Moreover, the expressions of multiple common regulators involved in apoptosis and autophagy were regulated by Par-4. Taken together, our results suggested a prognostic role of Par-4 in hypopharyngeal carcinoma and showed novel activity of Par-4 in apoptosis and autophagy induction.
前列腺凋亡反应蛋白 4(Par-4)的抑瘤活性已在多种人类癌症中得到证实。在这项研究中,我们首次证明,在接受单纯放疗或同步放化疗的下咽癌患者中,Par-4 表达水平越高,治疗反应越好。从机制上讲,Par-4 的高表达诱导下咽癌细胞凋亡,并使细胞对化疗药物或 X 射线照射敏感。除了诱导凋亡之外,令人感兴趣的是,自噬通量也在上调 Par-4 后增加,并促进细胞死亡。此外,Par-4 还调节了参与凋亡和自噬的多种常见调节剂的表达。总之,我们的研究结果表明 Par-4 在下咽癌中的预后作用,并揭示了 Par-4 在诱导凋亡和自噬中的新活性。